Raffles Medical eyes China healthcare growth but stays prudent on expansions
Megan Cheah
DeeperDive is a beta AI feature. Refer to full articles for the facts.
PRIVATE healthcare provider Raffles Medical Group has its eyes fixed on continuing to drive growth, even as it grapples with a slowdown in medical tourism amid the Covid-19 pandemic.
When Singapore shut its borders in early 2020, foreigners seeking medical help here had to be turned away. Private healthcare players who relied heavily on medical tourism turned to other avenues to get their care to overseas patients, including online consultations and delivering medication straight to patients’ homes.
While some companies would have baulked at the sudden shift in operations, Raffles Medical took the changes in stride.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
TRENDING NOW
Air India asks Tata, Singapore Airlines for funds after US$2.4 billion loss
‘Boring’ is the new black: The stars are aligning for a Singapore stock market revival
From 1MDB to ‘corporate mafia’: Is Malaysia facing a new governance test?
South-east Asian markets account for 8.8% of global capital inflows from 2021 to 2024: report